marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Aldeyra Therapeutics Financial Statements 2011-2024 | ALDX
Annual Financial Statements Aldeyra Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
228 M | 460 M | 198 M | 380 M | 147 M | 191 M | 121 M | 63.6 M | 41.5 M | 46.2 M | - | - | - |
Shares |
58.9 M | 58.4 M | 54 M | 34 M | 27.1 M | 21.7 M | 15.9 M | 11.4 M | 8.63 M | 3.82 M | - | - | - |
Historical Prices |
3.86 | 7.88 | 3.67 | 11.2 | 5.34 | 8.81 | 7.47 | 5.45 | 4.81 | 12.1 | - | - | - |
Net Income |
-37.5 M | -62 M | -57.8 M | -37.6 M | -60.8 M | -38.9 M | -22.3 M | -18.7 M | -12.1 M | -5.19 M | 13.1 M | -23.1 M | -2.38 M |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-42.8 M | -62.7 M | -56.2 M | -36.4 M | -63.1 M | -39.7 M | -22.5 M | -18.7 M | -12 M | -7.27 M | -3.68 M | - | - |
Interest Expense |
2.07 M | 1.69 M | 1.74 M | 1.9 M | 604 K | 147 K | 113 K | 106 K | 112 K | 244 K | 159 K | - | - |
EBITDA |
-42.5 M | -62.4 M | -56 M | -34.3 M | -56.4 M | -39.6 M | -22.5 M | -18.7 M | -12 M | -7.27 M | -3.68 M | -22.6 M | -2.1 M |
Operating Expenses |
- | - | - | 34.7 M | 56.5 M | 39.7 M | 22.5 M | 18.7 M | 12 M | 7.27 M | - | - | - |
General and Administrative Expenses |
13.3 M | 15.4 M | 11.3 M | 9.99 M | 12.2 M | 9.88 M | 6.19 M | 5.52 M | 4.41 M | 3.56 M | 2.13 M | 645 K | 744 K |
All numbers in USD currency
Quarterly Income Statement Aldeyra Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
59.5 M | 59.4 M | 59.4 M | 59.2 M | 59 M | 58.8 M | 58.8 M | 58.6 M | 58.5 M | 58.3 M | 58.3 M | 58.1 M | 58 M | 54.3 M | 45.6 M | 38.7 M | 37.8 M | 30.1 M | 29.2 M | 28.7 M | 27.1 M | 27 M | 27.1 M | 26.2 M | 21 M | 19.8 M | 19.4 M | 19.1 M | 15.6 M | 15.1 M | 13.8 M | 12.6 M | 12.5 M | 10.6 M | 9.71 M | 9.71 M | 9.71 M | 8.4 M | 6.67 M | 5.57 M | 5.57 M | 3.74 M | 327 K | 327 K | 317 K | 314 K | 314 K | - | - | - | - | - | - | - | - |
Net Income |
-15.1 M | -16.8 M | -8.08 M | - | -8.19 M | -8.99 M | -15.6 M | - | -14.6 M | -17.8 M | -16.8 M | - | -15.8 M | -14.9 M | -11.3 M | - | -8.87 M | -7.52 M | -9.87 M | - | -18.7 M | -13.3 M | -15.6 M | - | -10.8 M | -9.05 M | -8.4 M | - | -4.99 M | -5.31 M | -5.09 M | - | -4.78 M | -4.3 M | -4.97 M | - | -3.37 M | -2.23 M | -2.14 M | - | -2.01 M | -1.14 M | 402 K | - | 9.31 M | -1.57 M | 13.1 M | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-16.1 M | -18 M | -9.39 M | - | -9.55 M | -10.3 M | -16.8 M | - | -14.8 M | -17.7 M | -16.5 M | - | -15.4 M | -14.5 M | -10.8 M | - | -8.39 M | -7.11 M | -9.64 M | - | -19 M | -13.7 M | -17.4 M | - | -10.9 M | -9.17 M | -8.49 M | - | -5.02 M | -5.33 M | -5.1 M | - | -4.78 M | -4.3 M | -4.97 M | - | -3.34 M | -2.2 M | -2.11 M | - | -1.97 M | -1.65 M | -1.24 M | - | -1.17 M | -986 K | -292 K | - | - | - | - | - | - | - | - |
Interest Expense |
- | 478 K | 499 K | - | 539 K | 527 K | 491 K | - | 417 K | 410 K | 406 K | - | 413 K | 433 K | 483 K | - | 489 K | 486 K | 440 K | - | 29.2 K | 28.6 K | 1.96 K | - | 28.8 K | 26.4 K | 28 K | - | 27.6 K | 26.5 K | 26.8 K | - | 26.7 K | 27.8 K | 25 K | - | 28.1 K | 28.2 K | 28 K | - | 41.1 K | 56.2 K | 113 K | - | 14.5 K | 15.3 K | 15.4 K | - | - | - | - | - | - | - | - |
EBITDA |
- | - | -9.33 M | - | - | - | -16.7 M | - | -14.6 M | -17.7 M | -16.4 M | - | -15.2 M | -14.5 M | -10.8 M | - | -8.17 M | -6.96 M | -9.57 M | - | -18.9 M | -13.7 M | -17.4 M | - | -10.9 M | -9.14 M | -8.48 M | - | -4.99 M | -5.31 M | -5.09 M | - | -4.75 M | -4.28 M | -4.96 M | - | -3.33 M | -2.2 M | -2.11 M | - | -1.97 M | -1.65 M | -1.24 M | - | -1.17 M | -986 K | -292 K | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
3.7 M | 3.04 M | 3.21 M | - | 2.59 M | 3.38 M | 5.57 M | - | 3.24 M | 3.14 M | 4.25 M | - | 2.55 M | 3.07 M | 3.1 M | - | 2.26 M | 2.22 M | 3 M | - | 2.84 M | 3.12 M | 2.99 M | - | 3.07 M | 2.37 M | 1.89 M | - | 1.48 M | 1.48 M | 1.73 M | - | 1.4 M | 1.46 M | 1.46 M | - | 1.26 M | 955 K | 972 K | - | 772 K | 983 K | 801 K | - | 500 K | 661 K | 141 K | - | - | - | - | - | - | - | - |
All numbers in USD currency